Lv23
180 积分 2024-09-06 加入
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
8小时前
已完结
HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome
1天前
已关闭
Electrical power generation from moderate-temperature radiative thermal sources
1天前
已关闭
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
11个月前
已完结
Abstract OT3-4-01: A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017 study; PRIM-BC)
1年前
已关闭
皖公网安备34019202002308
